Keyphrases
Intravenous Bisphosphonates
100%
Bisphosphonate Therapy
100%
Bisphosphonates
100%
Older Patients with Cancer
100%
Atrial Fibrillation
100%
Hazard Ratio
80%
Supraventricular Tachycardia
80%
Patients with Cancer
60%
Surveillance Epidemiology
40%
Geographic Region
20%
Medicare
20%
Old Age
20%
High Dose
20%
Orally Administered
20%
Bone Metastasis
20%
Cancer Types
20%
Cardiovascular Adverse Events
20%
Adverse Events
20%
Dose Equivalent
20%
Intravenous Infusion
20%
Health Maintenance Organizations
20%
Medicare Part A
20%
Medicine and Dentistry
Apoplexy
100%
Bisphosphonate
100%
Atrial Fibrillation
100%
Hazard Ratio
40%
Supraventricular Tachycardia
40%
Adverse Event
20%
Medicare
20%
Surveillance, Epidemiology, and End Results
20%
Cardiovascular System
10%
Clinician
10%
Drug Megadose
10%
Intravenous Drug Administration
10%
Bone Metastasis
10%
Cancer Types
10%
Equivalent Dose
10%
Nursing and Health Professions
Bisphosphonic Acid Derivative
100%
Atrial Fibrillation
100%
Cerebrovascular Accident
100%
Hazard Ratio
40%
Supraventricular Tachycardia
40%
Medicare
20%
Adverse Event
20%
Malignant Neoplasm
10%
Drug Megadose
10%
Intravenous Drug Administration
10%
Health Maintenance Organization
10%
Bone Metastasis
10%
Equivalent Dose
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Bisphosphonic Acid Derivative
100%
Atrial Fibrillation
100%
Cerebrovascular Accident
100%
Supraventricular Tachycardia
40%
Adverse Event
20%
Bone Metastasis
10%